Opioid Crisis and Compliance

Julia Russell, Associate Director, Protiviti.

June 12, 2020

  • Compliance requirements and beyond: Evaluating the effectiveness of your compliance program and remedial efforts to implement or improve one in the face of the opioid epidemic

  • Digging into the common findings of Opioid Compliance Review and Drug Diversion Reviews

  • Using analytics to target key risks related to prescribing, drug diversion, and compliance with system and regulatory policies

This document is only available to subscribers